 Home > Medical News > Latest Medical News > GSK uses "delay fees" to restrict competition and fined how old-brand pharmaceutical companies do it under the patent cliff

GSK uses "delay fees" to restrict competition and fined how old-brand pharmaceutical companies do it under the patent cliff

 Last Update: 2021-07-29
 Source: Internet
 Author: User

Tags

3 8 1 2

research chemicals china

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The plummeting rate of return on investment may be one of the main reasons why the original research drug companies choose to purchase small, streamlined, and potential product pipelines at a high price when their patents expire
.
By acquiring innovative drug companies to obtain valuable products, it can effectively avoid the losses caused by the failure of self-research of innovative drugs by enterprises, and at the same time, it can greatly shorten the investment cycle of new drugs
.
In recent years, such acquisitions abound
.

In recent years, new targets and new treatment methods have continued to emerge.
However, in the face of the current situation where the rate of return on independent research and development is not as good as that of small pharmaceutical companies, established pharmaceutical companies are also inclined to M&A, or similarly, obtaining new projects by way of license in.

.
However, with the prosperity of this trend, how will the independent R&D strength of the companies that craze money in this mode be maintained?

If this article violates your rights, please contact us
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.